Tag Archives: Brazil
By Julian Upton | Published: February 11, 2014
Approximately $12.7 billion has been invested in Latin America’s (LATAM’s) pharmaceutical market through mergers and acquisitions (M&As) in recent years. And with untapped potential identified in countries across the region, companies are expected to seize upon further opportunities to drive future growth, says a new report from GlobalData.
By Ben Comer | Published: February 6, 2014
Pharma industry executives, FDA officials and Department of Justice attorneys speaking last week at CBI’s 11th annual Pharmaceutical Compliance Congress (PCC) offered solutions and threats to companies hoping to avoid enforcement actions.
By Julian Upton | Published: January 21, 2014
While the tide has been turning for pharma in the BRIC markets, they will continue to be important but only if the industry has learnt the hard lessons of the last few years. Speaking to Pharm Exec for the 2014 Industry Outlook, Reenita Das, Partner at Frost & Sullivan, says its now more important than […]
By Guest Blogger | Published: June 4, 2013
by Ryan O’Quinn & Sanya Sukduang One of the most promising pharmaceutical markets of the future is Brazil, a nation of nearly 200 million people with a universal healthcare system. Brazil’s infamously overloaded patent system has undergone a series of recent reforms. One such “reform,” however, greatly complicates biopharmaceutical patent practice: any Brazilian patent application […]
By Guest Blogger | Published: September 25, 2012
The Food and Drug Bar Travels to Brazil By: Frederick R. Ball Partner, Duane Morris LLP From September 9-12, , members of the U.S. food and drug law bar met with their Brazilian counterparts for the Food and Drug Law Institute’s conference “U.S. & Brazil: Navigating New Frontiers in Pharmaceutical, Medical Device & Food Law […]